Oral contraceptive use for the primary prevention of ovarian cancer / prepared for : Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by: Duke Evidence-based Practice Center ; investigators: Laura J. Havrilesky [and thirteen others].
Series InformationEvidence report/technology assessment ; no. 212.
AHRQ publication ; no. 13-E002-EF.
- Physical Description: 1 online resource (514 pages in various pagings) : illustrations (some color).
- Publisher: Rockville, MD : Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, 2013.
|Bibliography, etc. Note:||
Includes bibliographical references.
|Funding Information Note:||
Agency for Healthcare Research and Quality 290-2007-10066-I
|Source of Description Note:||
Description based on online resource; title from PDF title page (NIH, viewed July 23, 2020).
Search for related items by subject
|Subject:||Ovaries > Cancer > United States > Prevention.
Oral contraceptives > Side effects > United States.